nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—PTGS2—head and neck cancer	0.813	1	CbGaD
Tolmetin—Optic nerve disorder—Fluorouracil—head and neck cancer	0.0112	0.186	CcSEcCtD
Tolmetin—Skin irritation—Fluorouracil—head and neck cancer	0.00351	0.0581	CcSEcCtD
Tolmetin—Blood urea increased—Hydroxyurea—head and neck cancer	0.00199	0.0329	CcSEcCtD
Tolmetin—Ketorolac—PTGS2—head and neck cancer	0.00171	0.221	CrCbGaD
Tolmetin—Bromfenac—PTGS2—head and neck cancer	0.00164	0.212	CrCbGaD
Tolmetin—MPO—saliva—head and neck cancer	0.00146	0.216	CbGeAlD
Tolmetin—Lumiracoxib—PTGS2—head and neck cancer	0.00139	0.18	CrCbGaD
Tolmetin—Fenbufen—PTGS2—head and neck cancer	0.00126	0.164	CrCbGaD
Tolmetin—Dysuria—Hydroxyurea—head and neck cancer	0.00124	0.0205	CcSEcCtD
Tolmetin—Agranulocytosis—Vinblastine—head and neck cancer	0.00121	0.02	CcSEcCtD
Tolmetin—Weight increased—Hydroxyurea—head and neck cancer	0.0012	0.0199	CcSEcCtD
Tolmetin—Drowsiness—Hydroxyurea—head and neck cancer	0.00118	0.0195	CcSEcCtD
Tolmetin—Stomatitis—Hydroxyurea—head and neck cancer	0.00115	0.019	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.0011	0.0182	CcSEcCtD
Tolmetin—Blood pressure increased—Docetaxel—head and neck cancer	0.0011	0.0181	CcSEcCtD
Tolmetin—Suprofen—PTGS2—head and neck cancer	0.00105	0.136	CrCbGaD
Tolmetin—MPO—IL23-mediated signaling events—STAT3—head and neck cancer	0.000951	0.00849	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—CCND1—head and neck cancer	0.000941	0.00841	CbGpPWpGaD
Tolmetin—CXCL8—EBV LMP1 signaling—MAPK1—head and neck cancer	0.000937	0.00838	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—BCL2L1—head and neck cancer	0.000934	0.00834	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CCNA1—head and neck cancer	0.000924	0.00825	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—BCL2—head and neck cancer	0.000895	0.008	CbGpPWpGaD
Tolmetin—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000877	0.0145	CcSEcCtD
Tolmetin—PTGS2—C-MYB transcription factor network—CEBPA—head and neck cancer	0.000868	0.00775	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—PTGS2—head and neck cancer	0.00085	0.0076	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—GRP—head and neck cancer	0.000849	0.00759	CbGpPWpGaD
Tolmetin—Visual disturbance—Docetaxel—head and neck cancer	0.00084	0.0139	CcSEcCtD
Tolmetin—Stomatitis—Fluorouracil—head and neck cancer	0.000828	0.0137	CcSEcCtD
Tolmetin—Urinary tract infection—Fluorouracil—head and neck cancer	0.000826	0.0137	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—VEGFA—head and neck cancer	0.00082	0.00733	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—head and neck cancer	0.000817	0.0073	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Vinblastine—head and neck cancer	0.000808	0.0134	CcSEcCtD
Tolmetin—Epistaxis—Fluorouracil—head and neck cancer	0.000801	0.0133	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000796	0.0132	CcSEcCtD
Tolmetin—Agranulocytosis—Fluorouracil—head and neck cancer	0.000793	0.0131	CcSEcCtD
Tolmetin—PTGS2—C-MYB transcription factor network—CCNA1—head and neck cancer	0.000764	0.00683	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—BCL2—head and neck cancer	0.00076	0.00679	CbGpPWpGaD
Tolmetin—Oedema—Hydroxyurea—head and neck cancer	0.000753	0.0124	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—PIK3CA—head and neck cancer	0.00075	0.0067	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—MAPK1—head and neck cancer	0.000738	0.0066	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—EGFR—head and neck cancer	0.000738	0.0066	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000737	0.0122	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000716	0.0118	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—IL2—head and neck cancer	0.000711	0.00635	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—head and neck cancer	0.00071	0.00635	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—BCL2—head and neck cancer	0.00071	0.00635	CbGpPWpGaD
Tolmetin—Constipation—Vinblastine—head and neck cancer	0.000706	0.0117	CcSEcCtD
Tolmetin—PTGS1—Eicosanoid Synthesis—PTGS2—head and neck cancer	0.000705	0.0063	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CCNA1—head and neck cancer	0.000698	0.00624	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.000692	0.00618	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—MAPK3—head and neck cancer	0.000688	0.00615	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000675	0.0112	CcSEcCtD
Tolmetin—Indomethacin—PTGS2—head and neck cancer	0.00067	0.0868	CrCbGaD
Tolmetin—Somnolence—Hydroxyurea—head and neck cancer	0.000669	0.0111	CcSEcCtD
Tolmetin—PTGS1—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000666	0.00595	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—BCL2—head and neck cancer	0.000666	0.00595	CbGpPWpGaD
Tolmetin—Dyspepsia—Hydroxyurea—head and neck cancer	0.000663	0.011	CcSEcCtD
Tolmetin—PTGS1—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000659	0.00589	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—head and neck cancer	0.000658	0.00588	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—BCL2—head and neck cancer	0.000655	0.00585	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—MAPK1—head and neck cancer	0.000655	0.00585	CbGpPWpGaD
Tolmetin—Abdominal pain—Vinblastine—head and neck cancer	0.000652	0.0108	CcSEcCtD
Tolmetin—Constipation—Hydroxyurea—head and neck cancer	0.000644	0.0106	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—PTGS2—head and neck cancer	0.000633	0.00565	CbGpPWpGaD
Tolmetin—Weight increased—Docetaxel—head and neck cancer	0.000626	0.0104	CcSEcCtD
Tolmetin—Weight decreased—Docetaxel—head and neck cancer	0.000622	0.0103	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—TP53—head and neck cancer	0.00062	0.00554	CbGpPWpGaD
Tolmetin—TDO2—head—head and neck cancer	0.000617	0.0916	CbGeAlD
Tolmetin—PTGS2—cartilage tissue—head and neck cancer	0.000615	0.0912	CbGeAlD
Tolmetin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—head and neck cancer	0.00061	0.00545	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000609	0.00544	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—CASP8—head and neck cancer	0.000604	0.0054	CbGpPWpGaD
Tolmetin—Renal failure—Docetaxel—head and neck cancer	0.000603	0.00997	CcSEcCtD
Tolmetin—Stomatitis—Docetaxel—head and neck cancer	0.000598	0.00988	CcSEcCtD
Tolmetin—Body temperature increased—Hydroxyurea—head and neck cancer	0.000595	0.00984	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—HRAS—head and neck cancer	0.000593	0.0053	CbGpPWpGaD
Tolmetin—Asthenia—Vinblastine—head and neck cancer	0.000592	0.00979	CcSEcCtD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—head and neck cancer	0.000591	0.00528	CbGpPWpGaD
Tolmetin—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—head and neck cancer	0.00059	0.00527	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—STAT3—head and neck cancer	0.000582	0.0052	CbGpPWpGaD
Tolmetin—Epistaxis—Docetaxel—head and neck cancer	0.000578	0.00956	CcSEcCtD
Tolmetin—Agranulocytosis—Docetaxel—head and neck cancer	0.000572	0.00946	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—CCND1—head and neck cancer	0.000571	0.00511	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.00057	0.00509	CbGpPWpGaD
Tolmetin—CXCL8—IL8- and CXCR1-mediated signaling events—AKT1—head and neck cancer	0.000568	0.00507	CbGpPWpGaD
Tolmetin—Chest pain—Fluorouracil—head and neck cancer	0.000565	0.00935	CcSEcCtD
Tolmetin—Diarrhoea—Vinblastine—head and neck cancer	0.000565	0.00934	CcSEcCtD
Tolmetin—CXCL8—IL-3 Signaling Pathway—STAT3—head and neck cancer	0.000563	0.00503	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—CCND1—head and neck cancer	0.000562	0.00502	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000559	0.005	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—MAPK3—head and neck cancer	0.000556	0.00497	CbGpPWpGaD
Tolmetin—Hepatitis—Docetaxel—head and neck cancer	0.00055	0.0091	CcSEcCtD
Tolmetin—Dizziness—Vinblastine—head and neck cancer	0.000546	0.00903	CcSEcCtD
Tolmetin—Oedema—Fluorouracil—head and neck cancer	0.000542	0.00896	CcSEcCtD
Tolmetin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000542	0.00896	CcSEcCtD
Tolmetin—Asthenia—Hydroxyurea—head and neck cancer	0.00054	0.00893	CcSEcCtD
Tolmetin—CXCL8—IL-3 Signaling Pathway—MAPK3—head and neck cancer	0.000538	0.00481	CbGpPWpGaD
Tolmetin—PTGS2—S1P1 pathway—VEGFA—head and neck cancer	0.000532	0.00475	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00053	0.00877	CcSEcCtD
Tolmetin—Visual impairment—Docetaxel—head and neck cancer	0.00053	0.00877	CcSEcCtD
Tolmetin—CXCL8—TSLP Signaling Pathway—MAPK1—head and neck cancer	0.000529	0.00473	CbGpPWpGaD
Tolmetin—PTGS2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000529	0.00472	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—KISS1—head and neck cancer	0.000527	0.00471	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—HRAS—head and neck cancer	0.000526	0.0047	CbGpPWpGaD
Tolmetin—Vomiting—Vinblastine—head and neck cancer	0.000525	0.00868	CcSEcCtD
Tolmetin—PTGS1—Biological oxidations—NAT2—head and neck cancer	0.000524	0.00468	CbGpPWpGaD
Tolmetin—PTGS2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000523	0.00468	CbGpPWpGaD
Tolmetin—Erythema multiforme—Docetaxel—head and neck cancer	0.00052	0.00861	CcSEcCtD
Tolmetin—Headache—Vinblastine—head and neck cancer	0.000517	0.00855	CcSEcCtD
Tolmetin—Diarrhoea—Hydroxyurea—head and neck cancer	0.000515	0.00852	CcSEcCtD
Tolmetin—CXCL8—IL-3 Signaling Pathway—MAPK1—head and neck cancer	0.000512	0.00457	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IL2—head and neck cancer	0.000503	0.00449	CbGpPWpGaD
Tolmetin—PTGS2—S1P1 pathway—MAPK3—head and neck cancer	0.000503	0.00449	CbGpPWpGaD
Tolmetin—Dizziness—Hydroxyurea—head and neck cancer	0.000498	0.00823	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—CASP8—head and neck cancer	0.000493	0.0044	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CCND1—head and neck cancer	0.00049	0.00438	CbGpPWpGaD
Tolmetin—Nausea—Vinblastine—head and neck cancer	0.00049	0.00811	CcSEcCtD
Tolmetin—CXCL8—IL8- and CXCR2-mediated signaling events—AKT1—head and neck cancer	0.000486	0.00434	CbGpPWpGaD
Tolmetin—CXCL8—trachea—head and neck cancer	0.000484	0.0719	CbGeAlD
Tolmetin—Somnolence—Fluorouracil—head and neck cancer	0.000482	0.00797	CcSEcCtD
Tolmetin—Vomiting—Hydroxyurea—head and neck cancer	0.000479	0.00792	CcSEcCtD
Tolmetin—PTGS2—S1P1 pathway—MAPK1—head and neck cancer	0.000478	0.00427	CbGpPWpGaD
Tolmetin—Dyspepsia—Fluorouracil—head and neck cancer	0.000477	0.00789	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—PTEN—head and neck cancer	0.000473	0.00423	CbGpPWpGaD
Tolmetin—Headache—Hydroxyurea—head and neck cancer	0.000472	0.0078	CcSEcCtD
Tolmetin—CXCL8—ATF-2 transcription factor network—MAPK3—head and neck cancer	0.000464	0.00414	CbGpPWpGaD
Tolmetin—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000462	0.00413	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—PIK3CA—head and neck cancer	0.000459	0.0041	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—BCL2—head and neck cancer	0.000459	0.0041	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IL2—head and neck cancer	0.000457	0.00408	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TP53—head and neck cancer	0.000457	0.00408	CbGpPWpGaD
Tolmetin—Nausea—Hydroxyurea—head and neck cancer	0.000447	0.00739	CcSEcCtD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—head and neck cancer	0.000446	0.00398	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000444	0.00397	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL2—head and neck cancer	0.000443	0.00396	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—MAPK1—head and neck cancer	0.000441	0.00394	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—head and neck cancer	0.000441	0.00394	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—GRP—head and neck cancer	0.000434	0.00388	CbGpPWpGaD
Tolmetin—TDO2—lymph node—head and neck cancer	0.000432	0.0641	CbGeAlD
Tolmetin—Urticaria—Fluorouracil—head and neck cancer	0.00043	0.00712	CcSEcCtD
Tolmetin—Body temperature increased—Fluorouracil—head and neck cancer	0.000428	0.00708	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000424	0.00378	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—NAT2—head and neck cancer	0.000417	0.00372	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—EGFR—head and neck cancer	0.000413	0.00369	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—BCL2—head and neck cancer	0.000413	0.00369	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—HRAS—head and neck cancer	0.000411	0.00367	CbGpPWpGaD
Tolmetin—Chest pain—Docetaxel—head and neck cancer	0.000408	0.00675	CcSEcCtD
Tolmetin—CXCL8—Corticotropin-releasing hormone—IL2—head and neck cancer	0.000404	0.00361	CbGpPWpGaD
Tolmetin—PTGS1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000392	0.0035	CbGpPWpGaD
Tolmetin—Anaphylactic shock—Docetaxel—head and neck cancer	0.000391	0.00647	CcSEcCtD
Tolmetin—Oedema—Docetaxel—head and neck cancer	0.000391	0.00647	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—VEGFA—head and neck cancer	0.000388	0.00347	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—CASP8—head and neck cancer	0.000385	0.00344	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Docetaxel—head and neck cancer	0.000383	0.00633	CcSEcCtD
Tolmetin—CXCL8—TSLP Signaling Pathway—AKT1—head and neck cancer	0.000375	0.00335	CbGpPWpGaD
Tolmetin—Diarrhoea—Fluorouracil—head and neck cancer	0.000371	0.00613	CcSEcCtD
Tolmetin—TDO2—Metabolism—DPYD—head and neck cancer	0.000366	0.00327	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—GSTM1—head and neck cancer	0.000364	0.00326	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—AKT1—head and neck cancer	0.000363	0.00324	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—HRAS—head and neck cancer	0.00036	0.00322	CbGpPWpGaD
Tolmetin—Dizziness—Fluorouracil—head and neck cancer	0.000358	0.00593	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—PTGS2—head and neck cancer	0.000357	0.00319	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—MAPK3—head and neck cancer	0.000356	0.00318	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000353	0.00315	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00035	0.00313	CbGpPWpGaD
Tolmetin—Somnolence—Docetaxel—head and neck cancer	0.000348	0.00575	CcSEcCtD
Tolmetin—TDO2—Metabolism—YAP1—head and neck cancer	0.000347	0.0031	CbGpPWpGaD
Tolmetin—Vomiting—Fluorouracil—head and neck cancer	0.000344	0.0057	CcSEcCtD
Tolmetin—Dyspepsia—Docetaxel—head and neck cancer	0.000344	0.00569	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—PTEN—head and neck cancer	0.000342	0.00306	CbGpPWpGaD
Tolmetin—Headache—Fluorouracil—head and neck cancer	0.000339	0.00561	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—MAPK1—head and neck cancer	0.000339	0.00303	CbGpPWpGaD
Tolmetin—MPO—connective tissue—head and neck cancer	0.000337	0.0501	CbGeAlD
Tolmetin—PTGS2—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000336	0.003	CbGpPWpGaD
Tolmetin—Constipation—Docetaxel—head and neck cancer	0.000334	0.00553	CcSEcCtD
Tolmetin—CXCL8—Cellular responses to stress—SOD2—head and neck cancer	0.000334	0.00299	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—HRAS—head and neck cancer	0.000332	0.00297	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL2—head and neck cancer	0.000331	0.00296	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—MAPK3—head and neck cancer	0.000325	0.0029	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—TP53—head and neck cancer	0.000323	0.00289	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CCND1—head and neck cancer	0.000323	0.00289	CbGpPWpGaD
Tolmetin—Nausea—Fluorouracil—head and neck cancer	0.000322	0.00532	CcSEcCtD
Tolmetin—MPO—epithelium—head and neck cancer	0.00032	0.0475	CbGeAlD
Tolmetin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00032	0.00529	CcSEcCtD
Tolmetin—CXCL8—Cellular responses to stress—GPX1—head and neck cancer	0.000319	0.00285	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000318	0.00284	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—MAPK1—head and neck cancer	0.000309	0.00276	CbGpPWpGaD
Tolmetin—Body temperature increased—Docetaxel—head and neck cancer	0.000309	0.00511	CcSEcCtD
Tolmetin—Abdominal pain—Docetaxel—head and neck cancer	0.000309	0.00511	CcSEcCtD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—STAT3—head and neck cancer	0.000306	0.00273	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—GRP—head and neck cancer	0.000305	0.00273	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—MAPK3—head and neck cancer	0.000299	0.00267	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000299	0.00267	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—KISS1—head and neck cancer	0.000298	0.00266	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—AKT1—head and neck cancer	0.000293	0.00262	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—MAPK3—head and neck cancer	0.000292	0.00261	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—head and neck cancer	0.000288	0.00258	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—MAPK1—head and neck cancer	0.000285	0.00254	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	0.000285	0.00254	CbGpPWpGaD
Tolmetin—Asthenia—Docetaxel—head and neck cancer	0.000281	0.00464	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—MAPK1—head and neck cancer	0.000278	0.00249	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—MAPK1—head and neck cancer	0.000278	0.00249	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—KISS1—head and neck cancer	0.00027	0.00242	CbGpPWpGaD
Tolmetin—Diarrhoea—Docetaxel—head and neck cancer	0.000268	0.00443	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—MAPK3—head and neck cancer	0.000266	0.00238	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000262	0.00234	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—GSTM1—head and neck cancer	0.000259	0.00231	CbGpPWpGaD
Tolmetin—Dizziness—Docetaxel—head and neck cancer	0.000259	0.00428	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—MAPK1—head and neck cancer	0.000253	0.00226	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—EGFR—head and neck cancer	0.000253	0.00226	CbGpPWpGaD
Tolmetin—PTGS2—mouth—head and neck cancer	0.00025	0.037	CbGeAlD
Tolmetin—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000249	0.00223	CbGpPWpGaD
Tolmetin—Vomiting—Docetaxel—head and neck cancer	0.000249	0.00411	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—PIK3CA—head and neck cancer	0.000247	0.00221	CbGpPWpGaD
Tolmetin—MPO—lymphoid tissue—head and neck cancer	0.000247	0.0366	CbGeAlD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.000246	0.0022	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	0.000245	0.00219	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—GRP—head and neck cancer	0.000245	0.00219	CbGpPWpGaD
Tolmetin—Headache—Docetaxel—head and neck cancer	0.000245	0.00405	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	0.00024	0.00215	CbGpPWpGaD
Tolmetin—CXCL8—lymph node—head and neck cancer	0.000238	0.0353	CbGeAlD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000236	0.00211	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000236	0.00211	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—MAPK3—head and neck cancer	0.000234	0.00209	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TP53—head and neck cancer	0.000234	0.00209	CbGpPWpGaD
Tolmetin—Nausea—Docetaxel—head and neck cancer	0.000232	0.00384	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000225	0.00201	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—HRAS—head and neck cancer	0.000223	0.002	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—GRP—head and neck cancer	0.000223	0.00199	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—MAPK1—head and neck cancer	0.000222	0.00199	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—AKT1—head and neck cancer	0.000219	0.00196	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—BCL2—head and neck cancer	0.000216	0.00193	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—UROD—head and neck cancer	0.000216	0.00193	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TP53—head and neck cancer	0.000213	0.0019	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—TYMS—head and neck cancer	0.000208	0.00186	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GSTM1—head and neck cancer	0.000206	0.00184	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—AKT1—head and neck cancer	0.000202	0.0018	CbGpPWpGaD
Tolmetin—MPO—head—head and neck cancer	0.000199	0.0295	CbGeAlD
Tolmetin—TDO2—Metabolism—GPX1—head and neck cancer	0.000197	0.00176	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CYP1A1—head and neck cancer	0.000195	0.00174	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—STAT3—head and neck cancer	0.000194	0.00173	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—PIK3CA—head and neck cancer	0.000193	0.00172	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000191	0.00171	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000189	0.00169	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CCND1—head and neck cancer	0.000186	0.00166	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—MAPK3—head and neck cancer	0.000185	0.00165	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—MAPK1—head and neck cancer	0.000176	0.00157	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—UROD—head and neck cancer	0.000171	0.00153	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000167	0.0015	CbGpPWpGaD
Tolmetin—PTGS1—connective tissue—head and neck cancer	0.00016	0.0237	CbGeAlD
Tolmetin—CXCL8—Signaling Pathways—KISS1—head and neck cancer	0.00016	0.00143	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—AKT1—head and neck cancer	0.000158	0.00141	CbGpPWpGaD
Tolmetin—PTGS2—connective tissue—head and neck cancer	0.000153	0.0227	CbGeAlD
Tolmetin—PTGS1—epithelium—head and neck cancer	0.000152	0.0225	CbGeAlD
Tolmetin—CXCL8—Cellular responses to stress—VEGFA—head and neck cancer	0.000148	0.00132	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—head and neck cancer	0.000148	0.00132	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—STAT3—head and neck cancer	0.000146	0.00131	CbGpPWpGaD
Tolmetin—PTGS2—epithelium—head and neck cancer	0.000145	0.0215	CbGeAlD
Tolmetin—PTGS2—Spinal Cord Injury—IL2—head and neck cancer	0.000145	0.0013	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CCND1—head and neck cancer	0.000141	0.00126	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—MAPK3—head and neck cancer	0.00014	0.00125	CbGpPWpGaD
Tolmetin—MPO—lymph node—head and neck cancer	0.000139	0.0206	CbGeAlD
Tolmetin—PTGS1—trachea—head and neck cancer	0.000134	0.0199	CbGeAlD
Tolmetin—CXCL8—Cellular responses to stress—MAPK1—head and neck cancer	0.000133	0.00119	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000133	0.00119	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GRP—head and neck cancer	0.000132	0.00117	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000131	0.00117	CbGpPWpGaD
Tolmetin—PTGS2—trachea—head and neck cancer	0.000128	0.0191	CbGeAlD
Tolmetin—CXCL8—Signaling Pathways—STAT6—head and neck cancer	0.000128	0.00114	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—HRAS—head and neck cancer	0.000117	0.00105	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MAPK3—head and neck cancer	0.000117	0.00104	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTGS2—head and neck cancer	0.000116	0.00104	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—YAP1—head and neck cancer	0.000113	0.00101	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000112	0.001	CbGpPWpGaD
Tolmetin—PTGS2—lymphoid tissue—head and neck cancer	0.000112	0.0166	CbGeAlD
Tolmetin—CXCL8—Cellular responses to stress—TP53—head and neck cancer	0.000112	0.000998	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MAPK1—head and neck cancer	0.000111	0.000992	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—EGFR—head and neck cancer	0.000111	0.000992	CbGpPWpGaD
Tolmetin—PTGS1—thyroid gland—head and neck cancer	0.000106	0.0158	CbGeAlD
Tolmetin—TDO2—Metabolism—PTEN—head and neck cancer	0.000101	0.000904	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	9.62e-05	0.00086	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.52e-05	0.00085	CbGpPWpGaD
Tolmetin—PTGS1—head—head and neck cancer	9.43e-05	0.014	CbGeAlD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.42e-05	0.000842	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—head and neck cancer	9.32e-05	0.000833	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	9.29e-05	0.00083	CbGpPWpGaD
Tolmetin—PTGS2—head—head and neck cancer	9.01e-05	0.0134	CbGeAlD
Tolmetin—PTGS1—Metabolism—NAT2—head and neck cancer	8.96e-05	0.000801	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	8.39e-05	0.00075	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	7.94e-05	0.000709	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—DPYD—head and neck cancer	7.86e-05	0.000702	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.55e-05	0.000675	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	7.55e-05	0.000675	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	7.55e-05	0.000675	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.48e-05	0.000668	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—YAP1—head and neck cancer	7.46e-05	0.000666	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CA—head and neck cancer	7.14e-05	0.000638	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NAT2—head and neck cancer	7.11e-05	0.000636	CbGpPWpGaD
Tolmetin—PTGS1—lymph node—head and neck cancer	6.6e-05	0.0098	CbGeAlD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	6.55e-05	0.000585	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2—head and neck cancer	6.53e-05	0.000584	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	6.34e-05	0.000566	CbGpPWpGaD
Tolmetin—PTGS2—lymph node—head and neck cancer	6.31e-05	0.00936	CbGeAlD
Tolmetin—PTGS2—Metabolism—DPYD—head and neck cancer	6.24e-05	0.000557	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2—head and neck cancer	5.93e-05	0.00053	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—YAP1—head and neck cancer	5.92e-05	0.000529	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AKT1—head and neck cancer	5.83e-05	0.000521	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.6e-05	0.000501	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	5.35e-05	0.000478	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOTCH1—head and neck cancer	5.09e-05	0.000455	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.89e-05	0.000437	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MAPK3—head and neck cancer	4.77e-05	0.000426	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MAPK1—head and neck cancer	4.54e-05	0.000405	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EGFR—head and neck cancer	4.54e-05	0.000405	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—TYMS—head and neck cancer	4.48e-05	0.0004	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTM1—head and neck cancer	4.43e-05	0.000395	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CA—head and neck cancer	4.34e-05	0.000387	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GPX1—head and neck cancer	4.24e-05	0.000379	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP1A1—head and neck cancer	4.2e-05	0.000375	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CA—head and neck cancer	3.94e-05	0.000352	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.88e-05	0.000347	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HRAS—head and neck cancer	3.64e-05	0.000325	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—TYMS—head and neck cancer	3.55e-05	0.000318	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AKT1—head and neck cancer	3.54e-05	0.000316	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTM1—head and neck cancer	3.51e-05	0.000314	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2—head and neck cancer	3.5e-05	0.000313	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.45e-05	0.000308	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCND1—head and neck cancer	3.42e-05	0.000305	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GPX1—head and neck cancer	3.36e-05	0.000301	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP1A1—head and neck cancer	3.33e-05	0.000298	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTEN—head and neck cancer	3.3e-05	0.000295	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AKT1—head and neck cancer	3.22e-05	0.000287	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOTCH1—head and neck cancer	3.19e-05	0.000285	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—head and neck cancer	2.98e-05	0.000266	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STAT3—head and neck cancer	2.95e-05	0.000263	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK3—head and neck cancer	2.82e-05	0.000252	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.74e-05	0.000244	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK1—head and neck cancer	2.68e-05	0.00024	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EGFR—head and neck cancer	2.68e-05	0.000239	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTGS2—head and neck cancer	2.5e-05	0.000223	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CA—head and neck cancer	2.33e-05	0.000208	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—head and neck cancer	2.25e-05	0.000201	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTEN—head and neck cancer	2.18e-05	0.000194	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HRAS—head and neck cancer	2.15e-05	0.000192	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PTEN—head and neck cancer	2.06e-05	0.000184	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKT1—head and neck cancer	1.9e-05	0.00017	CbGpPWpGaD
Tolmetin—PTGS2—Disease—STAT3—head and neck cancer	1.84e-05	0.000165	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAPK3—head and neck cancer	1.76e-05	0.000157	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PTEN—head and neck cancer	1.73e-05	0.000154	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAPK1—head and neck cancer	1.68e-05	0.00015	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EGFR—head and neck cancer	1.68e-05	0.00015	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CA—head and neck cancer	1.54e-05	0.000137	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CA—head and neck cancer	1.46e-05	0.00013	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HRAS—head and neck cancer	1.35e-05	0.00012	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AKT1—head and neck cancer	1.25e-05	0.000112	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CA—head and neck cancer	1.22e-05	0.000109	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKT1—head and neck cancer	1.19e-05	0.000106	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AKT1—head and neck cancer	9.96e-06	8.89e-05	CbGpPWpGaD
